What's Hot

View all perspectives
      RT @drdavidliew: What do we do with PMR patients with subclinical GCA seen on ultrasound?

      Well, in these non-blinded co

      David Liew drdavidliew

      1 year 5 months ago
      What do we do with PMR patients with subclinical GCA seen on ultrasound? Well, in these non-blinded cohorts the subclinical GCA pts got more pred. Was it warranted? Hard to say. If we’re going to look for it, let’s try and figure out what it means POS0712 #EULAR2023 @RheumNow https://t.co/KmCcE0Nsu9
      RT @Janetbirdope: Rx of #lupus #SLE The most challenging seems to be longstanding & residual disease activity - dama

      Janet Pope Janetbirdope

      1 year 5 months ago
      Rx of #lupus #SLE The most challenging seems to be longstanding & residual disease activity - damage accumulates over time - esp if #glucocorticoids are used. Consider only as bridging. How to treat #lupus #EULAR2023 Boumpas ⁦@RheumNow⁩ #ClinicalPearl ⁦@eular_org⁩ https://t.co/heBbcRAjxO
      RT @drdavidliew: I mean, if proteomics is more your jive for GCA, we’ve got that too here at #EULAR2023. Definite pote

      David Liew drdavidliew

      1 year 5 months ago
      I mean, if proteomics is more your jive for GCA, we’ve got that too here at #EULAR2023. Definite potential for phenotyping a disease with diverse outcomes POS0694 @RheumNow https://t.co/tSWpZlUPoE
      RT @NoufAhmedAlham2: Could mitochondria play a role in the pathogenesis of Sjogrens disease?!

      #Eular2023 https://t.co/X

      Nouf Al hemmadi NoufAhmedAlham2

      1 year 5 months ago
      Could mitochondria play a role in the pathogenesis of Sjogrens disease?! #Eular2023 https://t.co/XndW4qFf3E
      RT @NoufAhmedAlham2: Malt lymphoma in Sjogrens disease and role of PET scan.
      When is PET scan suggestive?

      Follow:
      Compl

      Nouf Al hemmadi NoufAhmedAlham2

      1 year 5 months ago
      Malt lymphoma in Sjogrens disease and role of PET scan. When is PET scan suggestive? Follow: Complement RF Focus score SPEP #Eular2023 https://t.co/60l8iRNvQN
      RT @drdavidliew: Just a reminder: nr-axSpA isn’t destined to become r-axSpA/AS. Life is more complicated than that.

      B

      David Liew drdavidliew

      1 year 5 months ago
      Just a reminder: nr-axSpA isn’t destined to become r-axSpA/AS. Life is more complicated than that. Between the natural history and TNFi, very small conversion rate post-10y. Of course, whatever the x-rays, it can still disable though DESIR cohort POS0675 #EULAR2023 @RheumNow https://t.co/29HeJXpK2S
      RT @drdavidliew: Very early days, but it’s cool to see transcriptomics in GCA ➡️ in situ spatial profiling ➡️

      David Liew drdavidliew

      1 year 5 months ago
      Very early days, but it’s cool to see transcriptomics in GCA ➡️ in situ spatial profiling ➡️ drug-gene interactions ➡️ new therapeutic targets identified. Only time will tell if they will work, but very cool nevertheless. POS0091 (Mayo, La Jolla, & INSERM) #EULAR2023 @RheumNow https://t.co/n7raIENVOT
      RT @synovialjoints: I’ve been hearing the term ´Jackies’ used in talks on Jak inhibitors. A shorter form of JAKinib

      Dr. Antoni Chan synovialjoints

      1 year 5 months ago
      I’ve been hearing the term ´Jackies’ used in talks on Jak inhibitors. A shorter form of JAKinibs or JAKi #EULAR2023 @RheumNow
      RT @drdavidliew: In Brazil, if you’re in the early RA clinic (yellow bars) you do a lot better than other academic cli

      David Liew drdavidliew

      1 year 5 months ago
      In Brazil, if you’re in the early RA clinic (yellow bars) you do a lot better than other academic clinics, even w bDMARD access. Maybe it’s early Rx, or love & care, or other patient factors - but it’s a reminder that RA isn’t a level playing field. POS0055 #EULAR2023 @RheumNow https://t.co/jI2dvuIHWP
      RT @synovialjoints: The interface between cutaneous lymphoma and lupus panniculitis, characteristic differences and diag

      Dr. Antoni Chan synovialjoints

      1 year 5 months ago
      The interface between cutaneous lymphoma and lupus panniculitis, characteristic differences and diagnostic algorithm, Eviatar T, #EULAR2023 @RheumNow https://t.co/HRTQWS4Ctq
      RT @drdavidliew: Do we use too much PNL in GCA (when not using TCZ)? Could we wean quicker?

      Salvarini group n=22
      26w PN

      David Liew drdavidliew

      1 year 5 months ago
      Do we use too much PNL in GCA (when not using TCZ)? Could we wean quicker? Salvarini group n=22 26w PNL weaning protocol from GiACTA, but no TCZ 10/26 in relapse free remission at 1y Much less PNL, still some steroid AEs Way of the future for some? POS0728 #EULAR2023 @RheumNow https://t.co/qeZHeCi9vq
      RT @drdavidliew: Tapering pred in RA - this just rings true from everyday clinic life.

      Some patients just seem to hit a

      David Liew drdavidliew

      1 year 5 months ago
      Tapering pred in RA - this just rings true from everyday clinic life. Some patients just seem to hit a wall at PNL 2.5. Sometimes it’s GC withdrawal arthralgias/tertiary adrenal insufficiency, but often it’s genuine inflammation. I still wonder why? POS0050 #EULAR2023 @RheumNow https://t.co/JBh26VqPuM
      RT @Yuz6Yusof: #EULAR2023 #POS0120 From Sjogren to SLE. Interim analysis of Phase 2 RCT showed primary endpoint, SRI-4 +

      Md Yuzaiful Md Yusof Yuz6Yusof

      1 year 5 months ago
      #EULAR2023 #POS0120 From Sjogren to SLE. Interim analysis of Phase 2 RCT showed primary endpoint, SRI-4 + ability to sustain pred dose to ≤5 mg/d or ≤ BL from Wk16 to 28 was achieved more in Ianalumab (Bcell depletion & BAFF-R-i) vs PBO (44% vs 9%). Advance to Phase 3 @RheumNow https://t.co/Wg29uj5yqv
      RT @drdavidliew: Can machine learning help bDMARD selection in RA?

      Early days limited by the data available, so not gre

      David Liew drdavidliew

      1 year 5 months ago
      Can machine learning help bDMARD selection in RA? Early days limited by the data available, so not great yet, but efforts underway are a good start for an area where we need to do better than our status quo guessing. Watch this space POS0641 #EULAR2023 @RheumNow https://t.co/2j8H40iFWo
      RT @Janetbirdope: You need to see this! Albert with a Left V1 distribution of #shingles is a ‘bot’ who interacts wit

      Janet Pope Janetbirdope

      1 year 5 months ago
      You need to see this! Albert with a Left V1 distribution of #shingles is a ‘bot’ who interacts with #rheumatologists at #EULAR2023 ⁦@RheumNow⁩ ⁦@eular_org⁩ #artificial #intelligence https://t.co/gDwzc3NX7v

      Podcasts

      • ACR24 - RHEUMATOID ARTHRITIS
      • ACR24 - IL - 17
      • ACR24 - JAK TYK2

      Catch up on Conference Podcasts

      Key Conference Topics

      Additional Topics

      Filter by Type

      Featured Video

      Do you get our email newsletter?

      Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

      Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

      Copyright {{ 'now'|date('Y') }} All Rights Reserved.